Acorda Therapeutics, Inc. Made Big Gain
Acorda Therapeutics, Inc. (ACOR:NASDAQ) jumped higher at $0.88, representing a gain of 77.8%. On Mon, May 08, 2023, ACOR:NASDAQ touched a New 2-Week High of $0.88. The stock got featured on our News Catalysts scanner on Mon, May 08, 2023 at 07:43 AM in the 'AGREEMENT' category. From Mon, Apr 24, 2023, the stock recorded 40.00% Up Days and 36.36% Green Days
The stock spiked on Mon, May 08, 2023 at $1.21 with a volume of 40M+.
About Acorda Therapeutics, Inc. (ACOR:NASDAQ)
Acorda Therapeutics Inc is a biopharmaceutical company. It is engaged in the identification, development & commercialization of novel therapies for the treatment of neurological disorders.
Top 10 Gainers:
- Trevena, Inc. (TRVN:NASDAQ), 382.25%
- Ohmyhome Limited (OMH:NASDAQ), 328.71%
- Bellicum Pharmaceuticals, Inc. (BLCM:NASDAQ), 146.15%
- Acorda Therapeutics, Inc. (ACOR:NASDAQ), 77.78%
- Calithera Biosciences, Inc. (CALA:NASDAQ), 75.6%
- JE Cleantech Holdings Limited (JCSE:NASDAQ), 59.74%
- MoneyLion Inc. Class A (ML:NYSE), 49.92%
- Immuron Limited (IMRN:NASDAQ), 43.32%
- VivoPower International PLC (VVPR:NASDAQ), 41.7%
- Lightning eMotors Inc (ZEV:NYSE), 39.47%